Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis
- PMID: 15726622
- DOI: 10.1002/jso.20196
Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis
Abstract
Background: The prognostic impact of primary tumor resection in patients presenting with unresectable synchronous metastases from colorectal carcinoma (CRC) is not well established. In the present study, we analyzed fifteen factors to define the value of primary tumor resection with regard to prognosis.
Patients and methods: We identified 186 consecutive patients with proven stage IV CRC from the year 1995 to 2001. Variables were tested for their relationship to survival in univariate analyses with the Kaplan-Meier method and the log rank test. Factors that showed a significant impact were included in a Cox proportional hazards model. The tests were repeated for 107 patients who had no symptoms from their primary tumor.
Results: Overall there were six independent variables with a relationship to survival: performance status, ASA-class, CEA level, metastatic load, extent of primary tumor, and chemotherapy. In the asymptomatic patients we investigated 13 factors, 3 of which proved to be independent predictors of survival: performance status, CEA level, and chemotherapy. Resection of primary tumor was only predictive of survival if in-hospital mortality was excluded.
Conclusion: Resection of the tumor, if possible, is doubtless the best option for stage IV CRC patients with severe symptoms caused by their primary tumor. In asymptomatic patients, chemotherapy is preferable to surgery.
(c) 2005 Wiley-Liss, Inc.
Similar articles
-
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients.J Am Coll Surg. 2003 May;196(5):722-8. doi: 10.1016/S1072-7515(03)00136-4. J Am Coll Surg. 2003. PMID: 12742204
-
Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers.Int J Surg. 2010;8(4):305-13. doi: 10.1016/j.ijsu.2010.03.005. Epub 2010 Apr 7. Int J Surg. 2010. PMID: 20380899
-
Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.Int J Clin Oncol. 2015 Dec;20(6):1140-6. doi: 10.1007/s10147-015-0835-2. Epub 2015 May 7. Int J Clin Oncol. 2015. PMID: 25947545
-
Prognostic factors for survival in colorectal cancer patients.J Med Assoc Thai. 2010 Oct;93(10):1156-66. J Med Assoc Thai. 2010. PMID: 20973318
-
Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study.Dis Colon Rectum. 2011 Aug;54(8):930-8. doi: 10.1097/DCR.0b013e31821cced0. Dis Colon Rectum. 2011. PMID: 21730780
Cited by
-
Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases.J Gastrointest Surg. 2010 Aug;14(8):1258-64. doi: 10.1007/s11605-010-1250-7. Epub 2010 Jun 11. J Gastrointest Surg. 2010. PMID: 20544397
-
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.Cancers (Basel). 2023 Jan 31;15(3):900. doi: 10.3390/cancers15030900. Cancers (Basel). 2023. PMID: 36765854 Free PMC article. Review.
-
The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.Medicine (Baltimore). 2020 Feb;99(7):e19258. doi: 10.1097/MD.0000000000019258. Medicine (Baltimore). 2020. PMID: 32049866 Free PMC article.
-
Impact on survival benefits of asymptomatic primary tumor resection after bevacizumab plus FOLFIRI as first-line therapy for patients with metastatic colorectal cancer with synchronous unresectable metastasis.Int J Colorectal Dis. 2024 Oct 25;39(1):171. doi: 10.1007/s00384-024-04745-1. Int J Colorectal Dis. 2024. PMID: 39453531 Free PMC article.
-
Short- and long-term outcomes following laparoscopic palliative resection for patients with incurable, asymptomatic stage IV colorectal cancer: A multicenter study in Japan.J Anus Rectum Colon. 2018 May 25;1(4):125-130. doi: 10.23922/jarc.2017-012. eCollection 2017. J Anus Rectum Colon. 2018. PMID: 31583312 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical